Free Trial
OTCMKTS:NVTRQ

Nuvectra (NVTRQ) Stock Price, News & Analysis

$0.02 -0.01 (-25.00%)
As of 06/2/2020

About Nuvectra Stock (OTCMKTS:NVTRQ)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.0150
$0.0150
52-Week Range
$0.01
$4.30
Volume
382,600 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Receive NVTRQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvectra and its competitors with MarketBeat's FREE daily newsletter.

NVTRQ Stock News Headlines

Imasen Electric Industrial Co Ltd (7266)
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
See More Headlines

NVTRQ Stock Analysis - Frequently Asked Questions

Nuvectra's stock was trading at $0.0150 at the beginning of 2025. Since then, NVTRQ shares have increased by 0.0% and is now trading at $0.0150.
View the best growth stocks for 2025 here
.

Nuvectra Corp (OTCMKTS:NVTRQ) released its earnings results on Monday, October, 29th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.86) by $0.01. The business had revenue of $14.22 million for the quarter, compared to analysts' expectations of $12.38 million.

Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
10/29/2018
Today
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:NVTRQ
Previous Symbol
NASDAQ:NVTRV
Fax
N/A
Employees
197
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:NVTRQ) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners